$2.03
0.021.00%
Pre-Market: Nov 19, 5:46 PM EDT
Can Fite Biofarma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Can Fite Biofarma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-28 | $-0.01 | $-0.26 | 96.2 % |
Sep 2023 | 2023-11-30 | $-0.43 | $-0.44 | 2.27 % |
Jun 2023 | 2023-08-31 | $-0.40 | $-0.42 | 4.76 % |
Mar 2023 | 2023-06-01 | $-0.65 | $-1.52 | 57.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-28 | $155.00K | $100.00K | 55.0 % |
Sep 2023 | 2023-11-30 | $196.00K | $100.00K | 96.0 % |
Jun 2023 | 2023-08-31 | $196.00K | $100.00K | 9600.0 % |
Dec 2022 | 2023-03-30 | $197.00K | $330.00K | -40.3 % |
Can Fite Biofarma (CANF) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.01, which beat the estimate of $-0.26.
The Actual Revenue was $155K, which beat the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.